Virtu Financial’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-12,754
| Closed | -$169K | – | 2041 |
|
|
2019
Q1 | $169K | Sell |
12,754
-2,739
| -18% | -$36.3K | 0.01% | 1038 |
|
|
2018
Q4 | $339K | Sell |
15,493
-13,202
| -46% | -$289K | 0.02% | 656 |
|
|
2018
Q3 | $370K | Sell |
28,695
-11,453
| -29% | -$148K | 0.02% | 737 |
|
|
2018
Q2 | $725K | Buy |
40,148
+27,310
| +213% | +$493K | 0.04% | 583 |
|
|
2018
Q1 | $269K | Sell |
12,838
-561
| -4% | -$11.8K | 0.01% | 1137 |
|
|
2017
Q4 | $304K | Sell |
13,399
-18,289
| -58% | -$415K | 0.02% | 1259 |
|
|
2017
Q3 | $659K | Buy |
31,688
+590
| +2% | +$12.3K | 0.03% | 700 |
|
|
2017
Q2 | $835K | Buy |
31,098
+25,724
| +479% | +$691K | 0.12% | 162 |
|
|
2017
Q1 | $180K | Sell |
5,374
-6,349
| -54% | -$213K | 0.02% | 366 |
|
|
2016
Q4 | $563K | Sell |
11,723
-16
| -0.1% | -$768 | 0.06% | 226 |
|
|
2016
Q3 | $496K | Sell |
11,739
-8,465
| -42% | -$358K | 0.09% | 200 |
|
|
2016
Q2 | $1.31M | Buy |
20,204
+4,498
| +29% | +$291K | 0.17% | 114 |
|
|
2016
Q1 | $1.14M | Buy |
+15,706
| New | +$1.14M | 0.16% | 141 |
|
|
2015
Q4 | – | Sell |
-16,532
| Closed | -$1.08M | – | 468 |
|
|
2015
Q3 | $1.08M | Buy |
16,532
+10,279
| +164% | +$674K | 0.14% | 139 |
|
|
2015
Q2 | $277K | Buy |
+6,253
| New | +$277K | 0.02% | 266 |
|